The Technical Analyst
Select Language :
TherapeuticsMD Inc [TXMD]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

TherapeuticsMD Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

TherapeuticsMD Inc is listed at the  Exchange

0.44% $2.29

America/New_York / 28 mar 2024 @ 16:00


TherapeuticsMD Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 24.22 mill
EPS: 4.85
P/E: 0.470
Earnings Date: Apr 05, 2024
SharesOutstanding: 10.58 mill
Avg Daily Volume: 0.0190 mill
RATING 2024-03-28
A-
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Buy
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0.470 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.01x
Company: PE 0.470 | industry: PE 47.78
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 2.15 - 2.43

( +/- 6.07%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-12-05 Walker Marlan D Buy 70 000 Common Stock
2023-12-06 Walker Marlan D Sell 14 500 Common Stock
2023-12-07 Walker Marlan D Sell 4 550 Common Stock
2023-12-05 Walker Marlan D Sell 70 000 Restricted Stock Units
2023-11-15 Rubric Capital Management Lp Buy 877 192 Common Stock, par value $0.001 per share ("Common Stock")
INSIDER POWER
76.91
Last 94 transactions
Buy: 1 627 514 | Sell: 264 866

Forecast: 16:00 - $2.29

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.29
Forecast 2: 16:00 - $2.29
Forecast 3: 16:00 - $2.29
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.29 (0.44% )
Volume 0.0097 mill
Avg. Vol. 0.0190 mill
% of Avg. Vol 51.10 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for TherapeuticsMD Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for TherapeuticsMD Inc

RSI

Last 10 Buy & Sell Signals For TXMD

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            TherapeuticsMD Inc

TXMD

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Last 10 Buy Signals

Date Signal @
FRONTUSDMar 28 - 20:55$1.300
YFIIUSDMar 28 - 20:53$614.57
SCNSOLUSDMar 28 - 20:54222.33
BALUSDMar 28 - 20:54$5.14
BADGERUSDMar 28 - 20:527.25
GNOUSDMar 28 - 20:51$363.96
YGGUSDMar 28 - 20:49$1.182
SWETHUSDMar 28 - 20:443 709.37
GRPUSDMar 28 - 20:4417.20
PSGUSDMar 28 - 20:445.30

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.